Role of the MPTP in conditioning the heart - Translatability and mechanism

British Journal of Pharmacology

Volumn 172, Issue 8, 2015, Pages 2074-2084

  Ong, S B ^a   Dongworth, R K ^a   Cabrera Fuentes, H A ^b,c   Hausenloy, D J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c KAZAN FEDERAL UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE ISOENZYME 2; CALCINEURIN; CYCLOSPORIN A; CYTOCHROME C; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; PROTEIN KINASE C EPSILON; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; CARRIER PROTEIN;

ACUTE HEART INFARCTION; ALKALINIZATION; APOPTOSIS; CALCIUM CELL LEVEL; CARDIOVASCULAR RESPONSE; CELL DEATH; CELL GROWTH; CELL PH; CELL PROTECTION; CLINICAL TRIAL (TOPIC); CORONARY ARTERY BYPASS GRAFT; DRUG EFFICACY; DRUG MECHANISM; ELECTRON TRANSPORT; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART MUSCLE REVASCULARIZATION; HEART PROTECTION; HUMAN; MITOCHONDRIAL MEMBRANE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REPERFUSION INJURY; REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; CARDIAC MUSCLE; HEART INFARCTION PREVENTION; METABOLISM; MYOCARDIAL REPERFUSION INJURY;

ANIMALS; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM;

EID: 84925848193     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13013     Document Type: Review

References (132)

1. Alavian KN, Beutner G, Lazrove E, Sacchetti S, Park HA, Licznerski P, et al. (2014). An uncoupling channel within the c-subunit ring of the F1FO ATP synthase is the mitochondrial permeability transition pore. Proc Natl Acad Sci U S A 111: 10580-10585.
2. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013a). The Concise Guide to PHARMACOLOGY 2013/14: Enzymes. Br J Pharmacol 170: 1797-1867.
3. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Catterall WA, et al. (2013b). The Concise Guide to PHARMACOLOGY 2013/14: Ion Channels. Br J Pharmacol 170: 1607-1651.
4. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013c). The Concise Guide to PHARMACOLOGY 2013/14: Transporters. Br J Pharmacol 170: 1706-1796.
5. Ardehali H, O'Rourke B, (2005). Mitochondrial K(ATP) channels in cell survival and death. J Mol Cell Cardiol 39: 7-16.
6. Argaud L, Gateau-Roesch O, Chalabreysse L, Gomez L, Loufouat J, Thivolet-Bejui F, et al. (2004). Preconditioning delays Ca2+-induced mitochondrial permeability transition. Cardiovasc Res 61: 115-122.
7. Argaud L, Gateau-Roesch O, Raisky O, Loufouat J, Robert D, Ovize M, (2005). Postconditioning inhibits mitochondrial permeability transition. Circulation 111: 194-197.
8. Asimakis GK, Inners-McBride K, Medellin G, Conti VR, (1992). Ischemic preconditioning attenuates acidosis and postischemic dysfunction in isolated rat heart. Am J Physiol 263: H887-H894.
9. Baines CP, Zhang J, Wang GW, Zheng YT, Xiu JX, Cardwell EM, et al. (2002). Mitochondrial PKCepsilon and MAPK form signaling modules in the murine heart: enhanced mitochondrial PKCepsilon-MAPK interactions and differential MAPK activation in PKCepsilon-induced cardioprotection. Circ Res 90: 390-397.
10. Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, Hambleton MA, et al. (2005). Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434: 658-662.
11. Baines CP, Kaiser RA, Sheiko T, Craigen WJ, Molkentin JD, (2007). Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat Cell Biol 9: 550-555.
12. Basso E, Fante L, Fowlkes J, Petronilli V, Forte MA, Bernardi P, (2005). Properties of the permeability transition pore in mitochondria devoid of cyclophilin D. J Biol Chem 280: 18558-18561.
13. Bijur GN, Jope RS, (2003). Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3-kinase activation. J Neurochem 87: 1427-1435.
14. Boengler K, Hilfiker-Kleiner D, Heusch G, Schulz R, (2010). Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion. Basic Res Cardiol 105: 771-785.
15. Bonora M, Bononi A, De ME, Giorgi C, Lebiedzinska M, Marchi S, et al. (2013). Role of the c subunit of the FO ATP synthase in mitochondrial permeability transition. Cell Cycle 12: 674-683.
16. Bopassa JC, Ferrera R, Gateau-Roesch O, Couture-Lepetit E, Ovize M, (2006). PI 3-kinase regulates the mitochondrial transition pore in controlled reperfusion and postconditioning. Cardiovasc Res 69: 178-185.
17. Breivik L, Helgeland E, Aarnes EK, Mrdalj J, Jonassen AK, (2011). Remote postconditioning by humoral factors in effluent from ischemic preconditioned rat hearts is mediated via PI3K/Akt-dependent cell-survival signaling at reperfusion. Basic Res Cardiol 106: 135-145.
18. Budas GR, Disatnik MH, Mochly-Rosen D, (2009). Aldehyde dehydrogenase 2 in cardiac protection: a new therapeutic target? Trends Cardiovasc Med 19: 158-164.
19. Budas GR, Disatnik MH, Chen CH, Mochly-Rosen D, (2010). Activation of aldehyde dehydrogenase 2 (ALDH2) confers cardioprotection in protein kinase C epsilon (PKCvarepsilon) knockout mice. J Mol Cell Cardiol 48: 757-764.
20. Cereghetti GM, Stangherlin A, Martins DB, Chang CR, Blackstone C, Bernardi P, et al. (2008). Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria. Proc Natl Acad Sci U S A 105: 15803-15808.
21. Chang CR, Blackstone C, (2007). Cyclic AMP-dependent protein kinase phosphorylation of Drp1 regulates its GTPase activity and mitochondrial morphology. J Biol Chem 282: 21583-21587.
22. Chen CH, Budas GR, Churchill EN, Disatnik MH, Hurley TD, Mochly-Rosen D, (2008). Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science 321: 1493-1495.
23. Chiari P, Angoulvant D, Mewton N, Desebbe O, Obadia JF, Robin J, et al. (2014). Cyclosporine protects the heart during aortic valve surgery. Anesthesiology 121: 232-238.
24. Chouchani ET, Pell VR, Gaude E, Aksentijevi D, Sundier S, Robb EL, et al. (2014). Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature 515: 431-435.
25. Clarke SJ, Khaliulin I, Das M, Parker JE, Heesom KJ, Halestrap AP, (2008). Inhibition of mitochondrial permeability transition pore opening by ischemic preconditioning is probably mediated by reduction of oxidative stress rather than mitochondrial protein phosphorylation. Circ Res 102: 1082-1090.
26. Cohen MV, Yang XM, Downey JM, (2007). The pH hypothesis of postconditioning: staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis. Circulation 115: 1895-1903.
27. Cohen P, Frame S, (2001). The renaissance of GSK3. Nat Rev Mol Cell Biol 2: 769-776.
28. Costa AD, Garlid KD, (2008). Intramitochondrial signaling: interactions among mitoKATP, PKCepsilon, ROS, and MPT. Am J Physiol Heart Circ Physiol 295: H874-H882.
29. Costa AD, Garlid KD, West IC, Lincoln TM, Downey JM, Cohen MV, et al. (2005). Protein kinase G transmits the cardioprotective signal from cytosol to mitochondria. Circ Res 97: 329-336.
30. Costa AD, Jakob R, Costa CL, Andrukhiv K, West IC, Garlid KD, (2006). The mechanism by which the mitochondrial ATP-sensitive K+ channel opening and H2O2 inhibit the mitochondrial permeability transition. J Biol Chem 281: 20801-20808.
31. Crestanello JA, Lingle DM, Kamelgard J, Millili J, Whitman GJ, (1996). Ischemic preconditioning decreases oxidative stress during reperfusion: a chemiluminescence study. J Surg Res 65: 53-58.
32. Cribbs JT, Strack S, (2007). Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurin regulates mitochondrial fission and cell death. EMBO Rep 8: 939-944.
33. Crompton M, Costi A, Hayat L, (1987). Evidence for the presence of a reversible Ca2+-dependent pore activated by oxidative stress in heart mitochondria. Biochem J 245: 915-918.
34. Crompton M, Ellinger H, Costi A, (1988). Inhibition by cyclosporin A of a Ca2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem J 255: 357-360.
35. Das S, Wong R, Rajapakse N, Murphy E, Steenbergen C, (2008). Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation. Circ Res 103: 983-991.
36. Davidson SM, Hausenloy D, Duchen MR, Yellon DM, (2006). Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection. Int J Biochem Cell Biol 38: 414-419.
37. De PD, Chiari P, Teixeira G, Couture-Lepetit E, Abrial M, Argaud L, et al. (2013). Cyclosporine A at reperfusion fails to reduce infarct size in the in vivo rat heart. Basic Res Cardiol 108: 379.
38. Fang J, Wu L, Chen L, (2008). Postconditioning attenuates cardiocyte ultrastructure injury and apoptosis by blocking mitochondrial permeability transition in rats. Acta Cardiol 63: 377-387.
39. Ferdinandy P, Schulz R, Baxter GF, (2007). Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 59: 418-458.
40. Ferdinandy P, Hausenloy DJ, Heusch G, Baxter GF, Schulz R, (2014). Interaction of cardiovascular risk factors, comorbidities and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning: an update. Pharmacol Rev 66: 1142-1174.
41. Fryer RM, Eells JT, Hsu AK, Henry MM, Gross GJ, (2000). Ischemic preconditioning in rats: role of mitochondrial K(ATP) channel in preservation of mitochondrial function. Am J Physiol Heart Circ Physiol 278: H305-H312.
42. Fujita M, Asanuma H, Hirata A, Wakeno M, Takahama H, Sasaki H, et al. (2007). Prolonged transient acidosis during early reperfusion contributes to the cardioprotective effects of postconditioning. Am J Physiol Heart Circ Physiol 292: H2004-H2008.
43. Garcia-Dorado D, Inserte J, Ruiz-Meana M, Gonzalez MA, Solares J, Julia M, et al. (1997). Gap junction uncoupler heptanol prevents cell-to-cell progression of hypercontracture and limits necrosis during myocardial reperfusion. Circulation 96: 3579-3586.
44. Garcia-Dorado D, Agullo L, Sartorio CL, Ruiz-Meana M, (2009). Myocardial protection against reperfusion injury: the cGMP pathway. Thromb Haemost 101: 635-642.
45. Garlid KD, (2000). Opening mitochondrial K(ATP) in the heart-what happens, and what does not happen. Basic Res Cardiol 95: 275-279.
46. Garlid KD, Paucek P, Yarov-Yarovoy V, Murray HN, Darbenzio RB, D'Alonzo AJ, et al. (1997). Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection. Circ Res 81: 1072-1082.
47. Garlid KD, Costa AD, Cohen MV, Downey JM, Critz SD, (2004). Cyclic GMP and PKG activate mito K(ATP) channels in isolated mitochondria. Cardiovasc J S Afr 15: S5.
48. Ghaffari S, Kazemi B, Toluey M, Sepehrvand N, (2013). The effect of prethrombolytic cyclosporine-A injection on clinical outcome of acute anterior ST-elevation myocardial infarction. Cardiovasc Ther 31: e34-e39.
49. Giorgio V, von Stockum S, Antoniel M, Fabbro A, Fogolari F, Forte M, et al. (2013). Dimers of mitochondrial ATP synthase form the permeability transition pore. Proc Natl Acad Sci U S A 110: 5887-5892.
50. Gomez L, Paillard M, Thibault H, Derumeaux G, Ovize M, (2008). Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion. Circulation 117: 2761-2768.
51. Gong D, Zhang H, Hu S, (2013). Mitochondrial aldehyde dehydrogenase 2 activation and cardioprotection. J Mol Cell Cardiol 55: 58-63.
52. Griffiths EJ, Halestrap AP, (1995). Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem J 307 (Pt 1): 93-98.
53. Halestrap AP, Richardson AP, (2014). The mitochondrial permeability transition: a current perspective on its identity and role in ischaemia/reperfusion injury. J Mol Cell Cardiol pii: S0022-2828(14)00265-X.
54. Hall AR, Hausenloy DJ, (2012). The shape of things to come: mitochondrial fusion and fission in the adult heart. Cardiovasc Res 94: 391-392.
55. Hall AR, Burke N, Dongworth RK, Hausenloy DJ, (2014). Mitochondrial fusion and fission proteins: novel therapeutic targets for combating cardiovascular disease. Br J Pharmacol 171: 1890-1906.
56. Hanley PJ, Daut J, (2005). K(ATP) channels and preconditioning: a re-examination of the role of mitochondrial K(ATP) channels and an overview of alternative mechanisms. J Mol Cell Cardiol 39: 17-50.
57. Hausenloy D, Kunst G, Boston-Griffiths E, Kolvekar S, Chaubey S, John L, et al. (2014). The effect of cyclosporin-A on peri-operative myocardial injury in adult patients undergoing coronary artery bypass graft surgery: a randomised controlled clinical trial. Heart 100: 544-549.
58. Hausenloy DJ, (2013). Cardioprotection techniques: preconditioning, postconditioning and remote conditioning (basic science). Curr Pharm Des 19: 4544-4563.
59. Hausenloy DJ, Yellon DM, (2003). The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion. J Mol Cell Cardiol 35: 339-341.
60. Hausenloy DJ, Yellon DM, (2004). New directions for protecting the heart against ischaemia-reperfusion injury: targeting the reperfusion injury salvage kinase (RISK)-pathway. Cardiovasc Res 61: 448-460.
61. Hausenloy DJ, Yellon DM, (2007). Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. Heart Fail Rev 12: 217-234.
62. Hausenloy DJ, Yellon DM, (2008). Remote ischaemic preconditioning: underlying mechanisms and clinical application. Cardiovasc Res 79: 377-386.
63. Hausenloy DJ, Maddock HL, Baxter GF, Yellon DM, (2002). Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc Res 55: 534-543.
64. Hausenloy DJ, Duchen MR, Yellon DM, (2003). Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury. Cardiovasc Res 60: 617-625.
65. Hausenloy DJ, Yellon DM, Mani-Babu S, Duchen MR, (2004). Preconditioning protects by inhibiting the mitochondrial permeability transition. Am J Physiol Heart Circ Physiol 287: H841-H849.
66. Hausenloy DJ, Tsang A, Yellon DM, (2005). The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc Med 15: 69-75.
67. Hausenloy DJ, Ong SB, Yellon DM, (2009a). The mitochondrial permeability transition pore as a target for preconditioning and postconditioning. Basic Res Cardiol 104: 189-202.
68. Hausenloy DJ, Ong SB, Yellon DM, (2009b). The mitochondrial permeability transition pore as a target for preconditioning and postconditioning. Basic Res Cardiol 104: 189-202.
69. Hausenloy DJ, Lecour S, Yellon DM, (2011). RISK and SAFE pro-survival signalling pathways in ischaemic postconditioning: two sides of the same coin. Antioxid Redox Signal 14: 893-907.
70. Hausenloy DJ, Boston-Griffiths EA, Yellon DM, (2012). Cyclosporin A and cardioprotection: from investigative tool to therapeutic agent. Br J Pharmacol 165: 1235-1245.
71. Hausenloy DJ, Erik BH, Condorelli G, Ferdinandy P, Garcia-Dorado D, Heusch G, et al. (2013). Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res 98: 7-27.
72. Haworth RA, Hunter DR, (1979). The Ca2+-induced membrane transition in mitochondria. II. Nature of the Ca2+ trigger site. Arch Biochem Biophys 195: 460-467.
73. Hori M, Kitakaze M, Sato H, Takashima S, Iwakura K, Inoue M, et al. (1991). Staged reperfusion attenuates myocardial stunning in dogs. Role of transient acidosis during early reperfusion. Circulation 84: 2135-2145.
74. Huhn R, Heinen A, Hollmann MW, Schlack W, Preckel B, Weber NC, (2010). Cyclosporine A administered during reperfusion fails to restore cardioprotection in prediabetic Zucker obese rats in vivo. Nutr Metab Cardiovasc Dis 20: 706-712.
75. Hunter DR, Haworth RA, (1979a). The Ca2+-induced membrane transition in mitochondria. I. The protective mechanisms. Arch Biochem Biophys 195: 453-459.
76. Hunter DR, Haworth RA, (1979b). The Ca2+-induced membrane transition in mitochondria. III. Transitional Ca2+ release. Arch Biochem Biophys 195: 468-477.
77. Jaburek M, Costa AD, Burton JR, Costa CL, Garlid KD, (2006). Mitochondrial PKC epsilon and mitochondrial ATP-sensitive K+ channel copurify and coreconstitute to form a functioning signaling module in proteoliposomes. Circ Res 99: 878-883.
78. Javadov SA, Clarke S, Das M, Griffiths EJ, Lim KH, Halestrap AP, (2003). Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart. J Physiol 549: 513-524.
79. Juhaszova M, Zorov DB, Kim SH, Pepe S, Fu Q, Fishbein KW, et al. (2004). Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 113: 1535-1549.
80. Kamga PC, Mo L, Quesnelle K, Dagda RK, Murillo D, Geary L, et al. (2014). Nitrite activates protein kinase A in normoxia to mediate mitochondrial fusion and tolerance to ischaemia/reperfusion. Cardiovasc Res 101: 57-68.
81. Karlsson LO, Zhou AX, Larsson E, Astrom-Olsson K, Mansson C, Akyurek LM, et al. (2010). Cyclosporine does not reduce myocardial infarct size in a porcine ischemia-reperfusion model. J Cardiovasc Pharmacol Ther 15: 182-189.
82. Kim JS, Jin Y, Lemasters JJ, (2006). Reactive oxygen species, but not Ca2 + overloading, trigger pH- and mitochondrial permeability transition-dependent death of adult rat myocytes after ischemia-reperfusion. Am J Physiol Heart Circ Physiol 290: H2024-H2034.
83. Kobara M, Tatsumi T, Matoba S, Yamahara Y, Nakagawa C, Ohta B, et al. (1996). Effect of ischemic preconditioning on mitochondrial oxidative phosphorylation and high energy phosphates in rat hearts. J Mol Cell Cardiol 28: 417-428.
84. Kokoszka JE, Waymire KG, Levy SE, Sligh JE, Cai J, Jones DP, et al. (2004). The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature 427: 461-465.
85. Kwong JQ, Davis J, Baines CP, Sargent MA, Karch J, Wang X, et al. (2014a). Genetic deletion of the mitochondrial phosphate carrier desensitizes the mitochondrial permeability transition pore and causes cardiomyopathy. Cell Death Differ 21: 1209-1217.
86. Kwong JQ, Davis J, Baines CP, Sargent MA, Karch J, Wang X, et al. (2014b). Genetic deletion of the mitochondrial phosphate carrier desensitizes the mitochondrial permeability transition pore and causes cardiomyopathy. Cell Death Differ 21: 1209-1217.
87. Lacerda L, Somers S, Opie LH, Lecour S, (2009). Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway. Cardiovasc Res 84: 201-208.
88. Laclau MN, Boudina S, Thambo JB, Tariosse L, Gouverneur G, Bonoron-Adele S, et al. (2001). Cardioprotection by ischemic preconditioning preserves mitochondrial function and functional coupling between adenine nucleotide translocase and creatine kinase. J Mol Cell Cardiol 33: 947-956.
89. Lecour S, (2009). Activation of the protective survivor activating factor enhancement (SAFE) pathway against reperfusion injury: does it go beyond the RISK pathway? J Mol Cell Cardiol 47: 32-40.
90. Li ZH, Jiang CR, Xia ML, Ye HW, Guan SD, Gao Q, (2010). [Activation of mitochondrial aldehyde dehydrogenase 2 and inhibition of mitochondrial permeability transition pore involved in cardioprotection of ethanol postconditioning]. Zhejiang Da Xue Xue Bao Yi Xue Ban 39: 566-571.
91. Lim SY, Davidson SM, Hausenloy DJ, Yellon DM, (2007). Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore. Cardiovasc Res 75: 530-535.
92. Liu Y, Sato T, O'Rourke B, Marban E, (1998). Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation 97: 2463-2469.
93. Luedde M, Lutz M, Carter N, Sosna J, Jacoby C, Vucur M, et al. (2014). RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction. Cardiovasc Res 103: 206-216.
94. Mewton N, Croisille P, Gahide G, Rioufol G, Bonnefoy E, Sanchez I, et al. (2010). Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction. J Am Coll Cardiol 55: 1200-1205.
95. Murata M, Akao M, O'Rourke B, Marban E, (2001). Mitochondrial ATP-sensitive potassium channels attenuate matrix Ca(2+) overload during simulated ischemia and reperfusion: possible mechanism of cardioprotection. Circ Res 89: 891-898.
96. Murry CE, Jennings RB, Reimer KA, (1986). Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136.
97. Murry CE, Richard VJ, Reimer KA, Jennings RB, (1990). Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 66: 913-931.
98. Nederlof R, Eerbeek O, Hollmann MW, Southworth R, Zuurbier CJ, (2014). Targeting hexokinase II to mitochondria to modulate energy metabolism and reduce ischaemia-reperfusion injury in heart. Br J Pharmacol 171: 2067-2079.
99. Nishihara M, Miura T, Miki T, Tanno M, Yano T, Naitoh K, et al. (2007). Modulation of the mitochondrial permeability transition pore complex in GSK-3beta-mediated myocardial protection. J Mol Cell Cardiol 43: 564-570.
100. Nishino Y, Webb IG, Davidson SM, Ahmed AI, Clark JE, Jacquet S, et al. (2008). Glycogen synthase kinase-3 inactivation is not required for ischemic preconditioning or postconditioning in the mouse. Circ Res 103: 307-314.
101. Ong SB, Hausenloy DJ, (2010). Mitochondrial morphology and cardiovascular disease. Cardiovasc Res 88: 16-29.
102. Ong SB, Subrayan S, Lim SY, Yellon DM, Davidson SM, Hausenloy DJ, (2010). Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation 121: 2012-2022.
103. Ong SB, Hall AR, Hausenloy DJ, (2013). Mitochondrial dynamics in cardiovascular health and disease. Antioxid Redox Signal 19: 400-414.
104. Ong SB, Hall AR, Dongworth RK, Kalkhoran S, Pyakurel A, Scorrano L, et al. (2014). Akt protects the heart against ischaemia-reperfusion injury by modulating mitochondrial morphology. Thromb Haemost 113. [Epub ahead of print].
105. Ovize M, Baxter GF, Di Lisa F, Ferdinandy P, Garcia-Dorado D, Hausenloy DJ, et al. (2010). Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res 87: 406-423.
106. Pan X, Liu J, Nguyen T, Liu C, Sun J, Teng Y, et al. (2013). The physiological role of mitochondrial calcium revealed by mice lacking the mitochondrial calcium uniporter. Nat Cell Biol 15: 1464-1472.
107. Parra V, Verdejo HE, Iglewski M, Del CA, Troncoso R, Jones D, et al. (2014). Insulin stimulates mitochondrial fusion and function in cardiomyocytes via the Akt-mTOR-NFkappaB-Opa-1 signaling pathway. Diabetes 63: 75-88.
108. Pasdois P, Parker JE, Griffiths EJ, Halestrap AP, (2011). The role of oxidized cytochrome c in regulating mitochondrial reactive oxygen species production and its perturbation in ischaemia. Biochem J 436: 493-505.
109. Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al.; NC-IUPHAR (2014). The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledge base of drug targets and their ligands. Nucleic Acids Res 42 (Database Issue): D1098-1106.
110. Peart JN, Pepe S, Reichelt ME, Beckett N, See HL, Ozberk V, et al. (2014). Dysfunctional survival-signaling and stress-intolerance in aged murine and human myocardium. Exp Gerontol 50: 72-81.
111. Piot C, Croisille P, Staat P, Thibault H, Rioufol G, Mewton N, et al. (2008). Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med 359: 473-481.
112. Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P, (1993). Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 87: 893-899.
113. Robin E, Guzy RD, Loor G, Iwase H, Waypa GB, Marks JD, et al. (2007). Oxidant stress during simulated ischemia primes cardiomyocytes for cell death during reperfusion. J Biol Chem 282: 19133-19143.
114. Ruiz-Meana M, Garcia-Dorado D, Miro-Casas E, Abellan A, Soler-Soler J, (2006). Mitochondrial Ca(2+) uptake during simulated ischemia does not affect permeability transition pore opening upon simulated reperfusion. Cardiovasc Res 71: 715-724.
115. Ruiz-Meana M, Abellan A, Miro-Casas E, Agullo E, Garcia-Dorado D, (2009). Role of sarcoplasmic reticulum in mitochondrial permeability transition and cardiomyocyte death during reperfusion. Am J Physiol Heart Circ Physiol 297: H1281-H1289.
116. Ruiz-Meana M, Inserte J, Fernandez-Sanz C, Hernando V, Miro-Casas E, Barba I, et al. (2011). The role of mitochondrial permeability transition in reperfusion-induced cardiomyocyte death depends on the duration of ischemia. Basic Res Cardiol 106: 1259-1268.
117. Sanada S, Asanuma H, Tsukamoto O, Minamino T, Node K, Takashima S, et al. (2004). Protein kinase A as another mediator of ischemic preconditioning independent of protein kinase C. Circulation 110: 51-57.
118. Smeele KM, Southworth R, Wu R, Xie C, Nederlof R, Warley A, et al. (2011). Disruption of hexokinase II-mitochondrial binding blocks ischemic preconditioning and causes rapid cardiac necrosis. Circ Res 108: 1165-1169.
119. Smith CC, Mocanu MM, Davidson SM, Wynne AM, Simpkin JC, Yellon DM, (2006). Leptin, the obesity-associated hormone, exhibits direct cardioprotective effects. Br J Pharmacol 149: 5-13.
120. Sun HY, Wang NP, Kerendi F, Halkos M, Kin H, Guyton RA, et al. (2005). Hypoxic postconditioning reduces cardiomyocyte loss by inhibiting ROS generation and intracellular Ca2+ overload. Am J Physiol Heart Circ Physiol 288: H1900-H1908.
121. Tong H, Imahashi K, Steenbergen C, Murphy E, (2002). Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3-kinase-dependent pathway is cardioprotective. Circ Res 90: 377-379.
122. Vasiliou V, Nebert DW, (2005). Analysis and update of the human aldehyde dehydrogenase (ALDH) gene family. Hum Genomics 2: 138-143.
123. Wang L, Oka N, Tropak M, Callahan J, Lee J, Wilson G, et al. (2008). Remote ischemic preconditioning elaborates a transferable blood-borne effector that protects mitochondrial structure and function and preserves myocardial performance after neonatal cardioplegic arrest. J Thorac Cardiovasc Surg 136: 335-342.
124. Wegrzyn J, Potla R, Chwae YJ, Sepuri NB, Zhang Q, Koeck T, et al. (2009). Function of mitochondrial Stat3 in cellular respiration. Science 323: 793-797.
125. Weinbrenner C, Liu GS, Downey JM, Cohen MV, (1998). Cyclosporine A limits myocardial infarct size even when administered after onset of ischemia. Cardiovasc Res 38: 678-684.
126. Wolfe CL, Sievers RE, Visseren FL, Donnelly TJ, (1993). Loss of myocardial protection after preconditioning correlates with the time course of glycogen recovery within the preconditioned segment. Circulation 87: 881-892.
127. Xiao XH, Allen DG, (1999). Role of Na(+)/H(+) exchanger during ischemia and preconditioning in the isolated rat heart. Circ Res 85: 723-730.
128. Xiao XH, Allen DG, (2000). Activity of the Na(+)/H(+) exchanger is critical to reperfusion damage and preconditioning in the isolated rat heart. Cardiovasc Res 48: 244-253.
129. Xu M, Wang Y, Hirai K, Ayub A, Ashraf M, (2001). Calcium preconditioning inhibits mitochondrial permeability transition and apoptosis. Am J Physiol Heart Circ Physiol 280: H899-H908.
130. Yellon DM, Hausenloy DJ, (2007). Myocardial reperfusion injury. N Engl J Med 357: 1121-1135.
131. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, et al. (2003). Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285: H579-H588.
132. Zuurbier CJ, Smeele KM, Eerbeek O, (2009). Mitochondrial hexokinase and cardioprotection of the intact heart. J Bioenerg Biomembr 41: 181-185.